Abiopharma

🔍 Merrell Brendan W. (Executive)

Company: OptimizeRx Corp (OPRX)

Report Date: 2025-12-11

Detailed Transactions and Holdings:

• Sold 712 shares of Common Stock at $14.03 per share (Direct)
  Date: 2025-12-11 | Code: F | equity_swap_involved: 0 | shares_owned_after: 26,496.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
• REMARKS: The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.